The Information Revolution
Managed care demands new types of information, integrated across the continuum of care, redefining the way customers value high tech equipment and creating new contexts for the clinical information that equipment produces. Hewlett-Packard is leading the manufacturers’ response.
You may also be interested in...
Just as it did when it bought Datex-Ohmeda, the anesthesia equipment company, Instrumentarium has scooped up a US firm that built a US presence in an important technology area. This time the play is for SpaceLabs in critical care monitoring. For SpaceLabs, the acquisition ends a difficult time as it tried to remain independent in the face of a declining share price and heightened competition from some of capital equipment's largest players.
Just three years after its founding, Chinese cell therapy developer IASO Bio already has two assets in clinical development and the Nanjing firm has recently attracted $60m in financing. In an exclusive interview, its R&D head told Scrip that speed and partnerships are propelling Chinese developers on a trajectory to quickly catch up with the west in the emerging cell-therapy arena.
Updated guidance from England’s National Institute for Health and Care Excellence says two neurostimulation systems for treatment-resistant depression and epilepsy should only be used under special conditions. See what LivaNova’s VP of difficult-to-treat depression, Jonathan Walker, said about it here.